API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Nicotinamide riboside chloride: biological activities and preclinical studies

Nicotinamide riboside chloride increases NAD+ levels, has similar toxicity to nicotinamide, and shows potential benefits in metabolism, liver health, and exercise performance.

Jan 24,2024  API

Ascorbyl Glucoside: A Stable and Effective Skincare Ingredient with Multiple Efficacy

Ascorbyl glucoside is a stable and effective skincare ingredient that brightens complexion, reduces pigmentation, promotes collagen synthesis, and protects against UV damage.

Jan 23,2024  API

Carbohydrazide: Biological Properties and Applications in Different Fields

Carbohydrazide displays diverse biological activities and finds applications in solar cells and coordination compounds, showcasing its potential in biochemistry and materials science.

Jan 23,2024  API

Bemotrizinol: A New Sunscreen Active Ingredient considered by FDA

Bemotrizinol is a photostable UV filter with enhanced fat solubility and is being considered for inclusion in OTC sunscreen products by the FDA.

Jan 23,2024  API

Puerarin in the root of kudzu: pharmacokinetics and adverse effects

Puerarin is a flavonoid extracted from the root of kudzu with therapeutic effects, but low bioavailability. Caution needed in pregnancy.

Jan 23,2024  API

Gefitinib: Pharmacodynamic Properties, Dosage and Administration

Gefitinib demonstrates pharmacodynamic properties in inhibiting downstream signal transduction in NSCLC, and its recommended dosage is 250mg once daily.

Jan 23,2024  API

The synthesis method of Polatuzumab vedotin

Polatuzumab vedotin is an antibody-drug conjugate comprising a monoclonal antibody against CD79b (a B cell receptor component) covalently conjugated to the anti-mitotic cytotoxic agent monomethyl auri

Jan 22,2024  API

Zinc Sulfide Nanoparticles: Unique Properties and Potential Applications in Biomedicine

Zinc sulfide nanoparticles possess unique properties for biomedical applications, including wound healing, cancer treatment, and imaging.

Jan 22,2024  API

Bromelain: Source, Antimicrobial Efficacy and Therapeutic Applications

Bromelain, a protein found in pineapple stems, has diverse applications in medicine due to its antimicrobial properties, and potential in treating various conditions.

Jan 22,2024  API

Nano-Platform Carrier Enhances Delivery of Citicoline Sodium for Alzheimer's Disease Treatment

Nano-platform carrier enable targeted delivery of Citicoline sodium to the brain, showing potential as anti-Alzheimer's drug by boosting cholinergic activity and reducing neurodegenerative damage.

Jan 22,2024  API
Prev12345678910...Next>  Go to Page